Adaptive Biotechnologies is trading 4.3% down at $21.94 on profit-taking following a sharp multi-day rally that recently pushed shares near 52-week highs.
- The stock is undergoing a period of consolidation after moving above most analyst price targets due to strong momentum from earlier earnings.
- Today's pullback appears to be a technical correction rather than a reaction to fresh company-specific news or macroeconomic shocks.